Uscom aiming for $20m revenue in FY20
Elise ShawMarkets Online Editor
Patersons has a "speculative buy" on Uscom, a medical device company providing premium, noninvasive technologies to clinicians to improve patient care and health outcomes.
"It has built a portfolio of high quality cardiac, blood pressure and pulmonary monitoring devices targeting global growth markets.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles